Market claims and efficacy information in direct-to-consumer prescription drug print advertisements
This study examined the impact of “New” and “#1 Prescribed” market claims and quantitative efficacy information on perceptions of a hypothetical prescription drug in a direct-to-consumer (DTC) print advertisement. We examined two market claims (New and #1 Prescribed), two efficacy levels (higher and...
Main Authors: | Aikin, K.J (Author), Betts, K.R (Author), Keisler, A. (Author), Ziemer, K.S (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-Liss Inc.
2019
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
The Influence of Direct-to-Consumer Advertising: Who Will Talk to Their Doctor as A Result of Prescription Drug Advertisement?
by: Chen, Hai Dubo
Published: (2005) -
The Use of Direct-to-Consumer (DTC) Pharmaceutical Advertisements in Televised and Print Formats as a Teaching Tool in a Pharmacy Curriculum
by: Asha Suryanarayanan
Published: (2021-09-01) -
Comparative Advertising: A Factual Claim or an Evaluative Claim
by: Kodagoda Peiris, Ishan Chalindha
Published: (2018) -
Weasel claims in advertisements in English and Serbian
by: Vidaković Mirna M., et al.
Published: (2017-01-01) -
Future Challenges and Opportunities in Online Prescription Drug Promotion Research; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
by: Brian G. Southwell, et al.
Published: (2016-03-01)